Phase 1 Study of ONT-10 in Patients With Solid Tumors
Clinical trial NCT01556789 · COMPLETED
Trial details
- NCT number
- NCT01556789
- Sponsor
- Cascadian Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2015-05-01
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.